Insider · CIK 0001872069

Tattoli Mark Damian

Reports to the SEC for 2 companies · HOUSTON, TX

sec.gov

Transactions

Companies

Filings

CIK

0001872069

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−276 sh	$9.76	−$2,693.76	28,088.621
2026-10-01	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	+700 sh	—	—	28,364.621
2026-10-01	CLBCore Laboratories Inc. /DE/ · Restricted SharesM Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	−700 sh	—	—	250
2026-08-01	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−99 sh	$10.64	−$1,053.36	27,664.621
2026-08-01	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	+250 sh	—	—	27,763.621
2026-08-01	CLBCore Laboratories Inc. /DE/ · Restricted SharesM Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	−250 sh	—	—	950
2026-05-01	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−97 sh	$14.07	−$1,364.79	27,513.621
2026-05-01	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	+250 sh	—	—	27,610.621
2026-05-01	CLBCore Laboratories Inc. /DE/ · Restricted SharesM Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	−250 sh	—	—	1,200
2026-02-12	CLBCore Laboratories Inc. /DE/ · Performance SharesA Award	SVP, Gen Counsel & Secretary	AAward	+33.5K sh	—	—	33,490
2025-12-31	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−14.3K sh	$16.03	−$229K	27,360.621
2025-12-31	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	+25K sh	—	—	41,670.621
2025-12-31	CLBCore Laboratories Inc. /DE/ · Performance SharesM Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	−25K sh	—	—	0
2025-10-01	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−276 sh	$12.58	−$3,472.08	16,718.621
2025-10-01	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	+700 sh	—	—	16,994.621
2025-10-01	CLBCore Laboratories Inc. /DE/ · Restricted SharesM Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	−700 sh	—	—	1,450
2025-08-01	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−99 sh	$10.53	−$1,042.47	16,294.621
2025-08-01	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	+250 sh	—	—	16,393.621
2025-08-01	CLBCore Laboratories Inc. /DE/ · Restricted SharesM Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	−250 sh	—	—	2,150
2025-05-01	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−99 sh	$11.68	−$1,156.32	16,143.621
2025-05-01	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	+250 sh	—	—	16,242.621
2025-05-01	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−79 sh	$11.68	−$922.72	15,992.621
2025-05-01	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	+200 sh	—	—	16,071.621
2025-05-01	CLBCore Laboratories Inc. /DE/ · Restricted SharesM Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	−250 sh	—	—	2,400
2025-05-01	CLBCore Laboratories Inc. /DE/ · Restricted SharesM Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	−200 sh	—	—	2,650
2025-02-13	CLBCore Laboratories Inc. /DE/ · Performance SharesA Award	SVP, Gen Counsel & Secretary	AAward	+32.9K sh	—	—	32,912
2024-12-31	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−5,028 sh	$17.31	−$87K	15,871.621
2024-12-31	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	+9,604 sh	—	—	20,899.621
2024-12-31	CLBCore Laboratories Inc. /DE/ · Performance SharesM Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	−9,604 sh	—	—	0
2024-10-01	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−276 sh	$19.21	−$5,301.96	11,295.621
2024-10-01	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	+700 sh	—	—	11,571.621
2024-10-01	CLBCore Laboratories Inc. /DE/ · Restricted SharesM Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	−700 sh	—	—	2,850
2024-08-01	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−99 sh	$23.24	−$2,300.76	10,871.621
2024-08-01	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	+250 sh	—	—	10,970.621
2024-08-01	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−48 sh	$23.24	−$1,115.52	10,720.621
2024-08-01	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	+120 sh	—	—	10,768.621
2024-08-01	CLBCore Laboratories Inc. /DE/ · Restricted SharesM Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	−250 sh	—	—	3,550
2024-08-01	CLBCore Laboratories Inc. /DE/ · Restricted SharesM Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	−120 sh	—	—	3,800
2024-05-01	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−99 sh	$15.71	−$1,555.29	10,648.621
2024-05-01	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	+250 sh	—	—	10,747.621
2024-05-01	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−79 sh	$15.71	−$1,241.09	10,497.621
2024-05-01	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	+200 sh	—	—	10,576.621
2024-05-01	CLBCore Laboratories Inc. /DE/ · Restricted SharesM Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	−250 sh	—	—	3,920
2024-05-01	CLBCore Laboratories Inc. /DE/ · Restricted SharesM Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	−200 sh	—	—	4,170
2024-02-15	CLBCore Laboratories Inc. /DE/ · Performance SharesA Award	SVP, Gen Counsel & Secretary	AAward	+38K sh	—	—	38,002
2023-12-31	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−2,716 sh	$17.66	−$48K	10,376.621
2023-12-31	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−2,654 sh	$17.66	−$46.9K	10,438.621
2023-12-31	CLBCore Laboratories Inc. /DE/M Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	+6,900 sh	—	—	13,092.621
2023-12-29	CLBCore Laboratories Inc. /DE/ · Performance SharesM Exercise/Conversion	SVP, Gen Counsel & Secretary	MExercise/Conversion	−6,900 sh	—	—	0
2023-12-01	CLBCore Laboratories Inc. /DE/F Tax Payment	SVP, Gen Counsel & Secretary	FTax Payment	−62 sh	$18.07	−$1,120.34	6,192.621

Recent filings

Accepted (ET)
Oct 54
Tattoli Mark Damian0001193125-26-413742
SEC(opens sec.gov)
Aug 44
Tattoli Mark Damian0001193125-26-331829
SEC(opens sec.gov)
May 44
Tattoli Mark Damian0001193125-26-204136
SEC(opens sec.gov)
Feb 174
Tattoli Mark Damian0001193125-26-053614
SEC(opens sec.gov)
Jan 54
Tattoli Mark Damian0001193125-26-002257
SEC(opens sec.gov)
Oct 24
Tattoli Mark Damian0001193125-25-228649
SEC(opens sec.gov)
Aug 54
Tattoli Mark Damian0000950170-25-102465
SEC(opens sec.gov)
May 54
Tattoli Mark Damian0000950170-25-063437
SEC(opens sec.gov)

Companies

Address

6316 WINDFERN ROAD

HOUSTON, TX, 77040